BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November

Day

• 2
• 3
• 4
• 5
• 6
• 7

• Press Releases

  Olema Oncology to Participate in Upcoming November 2025 Investor Conferences

  November 3, 2025

   · 

  1 min read
• Press Releases

  U.S. FDA approves KYGEVVI® (doxecitine and doxribtimine), the first and only treatment for adults and children living with thymidine kinase 2 deficiency (TK2d)

  November 3, 2025

   · 

  13 min read
• Press Releases

  Fulcrum Therapeutics to Present New Clinical Data from the PIONEER trial of Pociredir in Sickle Cell Disease at the 67th American Society of Hematology Annual Meeting

  November 3, 2025

   · 

  4 min read
• Press Releases

  Sanuwave Will Host a Conference Call on November 7, 2025 at 8:30 AM (ET) to Present Q3 2025 Financial Results

  November 3, 2025

   · 

  2 min read
• Press Releases

  Protagonist Therapeutics Announces Oral and Poster Presentations on Rusfertide at the 67th Annual ASH Meeting

  November 3, 2025

   · 

  3 min read
• Press Releases

  Xilio Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - November 3, 2025

  November 3, 2025

   · 

  1 min read
• Press Releases

  Quest Diagnostics to Speak at Citi’s 2025 Global Healthcare Conference

  November 3, 2025

   · 

  1 min read
• Press Releases

  Solventum to Participate in the 2025 Stifel Healthcare Conference

  November 3, 2025

   · 

  1 min read
• Press Releases

  Arvinas to Present Preclinical Data for ARV-393 at the 2025 American Society of Hematology (ASH) Annual Meeting

  November 3, 2025

   · 

  4 min read
• Press Releases

  Syndax Reports Third Quarter 2025 Financial Results and Provides Business Update

  November 3, 2025

   · 

  15 min read